Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma

Abroad (travel likely)RecruitingPHASE4

Conditions

Asthma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The University of Pittsburgh Asthma Institute at UPMC, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Sally Wenzel, MD) · swenzel@pitt.edu · 412-647-9955
Contact: Study coordinator (John Moore) · mooreja6@upmc.edu · 412-648-6726

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

Asthma

Abroad (travel likely)RecruitingPHASE3

Newport Beach, United States · Aventura, United States

Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma

Safety in Asthma Patients

Abroad (travel likely)RecruitingPHASE1

Glendale, United States · Anaheim, United States

Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma

Mild to Moderate Asthma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Botany, Australia · Camberwell, Australia

Escitalopram in Asthma Patients With Frequent Exacerbation

Asthma

Abroad (travel likely)RecruitingPHASE2

Dallas, United States